Remdesivir Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
https://clinicaltrials.gov/ct2/show/Adaptive COVID-19 Treatment Trial (ACTT)
https://clinicaltrials.gov/ct2/show/Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
https://clinicaltrials.gov/ct2/show/Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment